Woodline Partners LP
Institutional investor · Portfolio as of Q2 2024
Top Holdings545 positions
Eli Lilly & Co | 284,589 | $257.7M | 2.5% | $422.06 | +111.26% | 19 qtrssince 2019-Q4 | Decreased 0 |
Regeneron Pharmaceuticals Inc | 181,897 | $191.2M | 1.8% | $793.22 | +31.26% | 15 qtrssince 2020-Q4 | Increased 51 |
Ovintiv Inc | 4.1M | $190M | 1.8% | $42.76 | +4.81% | 4 qtrssince 2023-Q3 | Increased 61 |
TE Connectivity Ltd | 1.1M | $161.2M | 1.5% | $137.83 | +58.38% | 4 qtrssince 2023-Q3 | Decreased 0 |
AbbVie Inc | 750,322 | $128.7M | 1.2% | $137.44 | +15.80% | 8 qtrssince 2022-Q3 | Increased 55 |
REVOLUTION MEDICINES INC | 3.3M | $127.7M | 1.2% | $24.45 | +58.76% | 16 qtrssince 2020-Q3 | Decreased 0 |
Oasis Petroleum Inc | 754,256 | $126.5M | 1.2% | $156.00 | -0.94% | 2 qtrssince 2024-Q1 | Increased 77 |
Facebook Inc | 247,590 | $124.8M | 1.2% | $224.72 | +122.70% | 8 qtrssince 2022-Q3 | Increased 48 |
Marsh & McLennan Cos Inc | 585,204 | $123.3M | 1.2% | $201.46 | 0.00% | 1 qtr | New 69 |
Centennial Resource Developmen | 7M | $112.6M | 1.1% | $11.50 | +31.36% | 5 qtrssince 2023-Q2 | Increased 56 |
Quest Diagnostics Inc | 783,903 | $107.3M | 1.0% | $130.04 | +0.56% | 2 qtrssince 2024-Q1 | Increased 76 |
Bonanza Creek Energy Inc | 1.5M | $102.8M | 1.0% | $64.06 | -2.81% | 4 qtrssince 2023-Q3 | Increased 68 |
Electronic Arts Inc | 735,372 | $102.5M | 1.0% | $138.33 | 0.00% | 1 qtr | New 58 |
Progressive Corp/The | 483,739 | $100.5M | 1.0% | $190.35 | +0.32% | 2 qtrssince 2024-Q1 | Increased 59 |
Zimmer Biomet Holdings Inc | 917,202 | $99.5M | 1.0% | $121.89 | -12.93% | 12 qtrssince 2021-Q3 | Increased 42 |
Arthur J Gallagher & Co | 377,269 | $97.8M | 0.9% | $246.33 | +3.28% | 2 qtrssince 2024-Q1 | Increased 50 |
Blueprint Medicines Corp | 880,147 | $94.9M | 0.9% | — | — | 14 qtrssince 2021-Q1 | Increased 45 |
Fortive Corp | 1.3M | $92.9M | 0.9% | $58.83 | -6.01% | 2 qtrssince 2024-Q1 | Increased 68 |
Amgen Inc | 292,133 | $91.3M | 0.9% | $262.70 | +11.21% | 7 qtrssince 2022-Q4 | Increased 67 |
Merck & Co Inc | 711,353 | $88.1M | 0.8% | $91.66 | +25.68% | 14 qtrssince 2021-Q1 | Decreased 0 |
Woodline Partners LP manages $10.5B across 545 positions as of Q2 2024. Top holdings: LLY (2.5%), REGN (1.8%), OVV (1.8%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2/5.0.
Active quarter - 188 new positions, 171 exits, 181 increased. Top move: CHRD (INCREASED, conviction 77). Portfolio: $10.5B across 545 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR